Overview

Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease

Status:
Completed

Trial end date:
2005-08-22

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess phosphate reduction and control in patients with End Stage Renal Disease treated with either lanthanum carbonate or sevelamer hydrochloride

Phase:

Phase 3

Details

Lead Sponsor:

Shire

Treatments:

Sevelamer